Tedizolid-13C-d3
(Synonyms: TR 700-13C,d3; Torezolid-13C,d3; DA-7157-13C,d3) 目录号 : GC48642An internal standard for the quantification of tedizolid
Cas No.:2931763-72-1
Sample solution is provided at 25 µL, 10mM.
Tedizolid-13C-d3 is intended for use as an internal standard for the quantification of tedizolid by GC- or LC-MS. Tedizolid is an oxazolidinone antibiotic and active metabolite of the antibiotic tedizolid phosphate .1 Tedizolid phosphate is converted to tedizolid by phosphatases in vivo. It is active against a wide variety of clinical isolates, including isolates of methicillin-resistant S. aureus (MRSA), E. faecalis, and penicillin-susceptible S. pneumoniae (MICs = 0.5, 0.5, and 0.25 µg/ml, respectively), as well as isolates of anaerobic bacteria (MICs = 0.25-4 µg/ml). Tedizolid protects against mortality in a mouse model of systemic methicillin-susceptible S. aureus (MSSA) infection (ED50 = 8.8 mg/kg).2
1.Schaadt, R., Sweeney, D.A., Shinabarger, D., et al.In vitro activity of TR-700, the active ingredient of the antibacterial prodrug TR-701, a novel oxazolidinone antibacterial agentAntimicrob. Agents Chemother.53(8)3236-3239(2009) 2.Im, W.B., Choi, S.H., Park, J.-Y., et al.Discovery of torezolid as a novel 5-hydroxymethyl-oxazolidinone antibacterial agentEur. J. Med. Chem.46(4)1027-1039(2011)
Cas No. | 2931763-72-1 | SDF | |
别名 | TR 700-13C,d3; Torezolid-13C,d3; DA-7157-13C,d3 | ||
Canonical SMILES | FC1=CC(N2C[C@H](CO)OC2=O)=CC=C1C3=CN=C(C4=NN([13C]([2H])([2H])[2H])N=N4)C=C3 | ||
分子式 | C16[13C]H12D3FN6O3 | 分子量 | 374.4 |
溶解度 | Acetonitrile: soluble,DMSO: soluble,Methanol: soluble | 储存条件 | -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.6709 mL | 13.3547 mL | 26.7094 mL |
5 mM | 0.5342 mL | 2.6709 mL | 5.3419 mL |
10 mM | 0.2671 mL | 1.3355 mL | 2.6709 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >99.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet